Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition: Obstructive Sleep Apnea Interventions: Drug: Acetazolamide 500 MG QHS; Drug: Eszopiclone 3 mg QHS Sponsors: University of California, Los Angeles; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Heart | Obstructive Sleep Apnea | Research | Sleep Apnea | Sleep Disorders | Sleep Medicine